Skip to content
Home/Companies/Diagnostics/DIESSE
DIESSE

DIESSE

Diagnostics·Italy·Exited 2025·Held 6yr
Entry
2019
Hold
6yr
Exit
2025

Who owns DIESSE?

DIESSE was owned by ARCHIMED through MED II (2017 vintage) from 2019 to 2025, exited via Secondary.

Buyer identity and MOIC available on Pro.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED II · 2017 · Buyout

Key facts

HQItaly
SectorDiagnostics
Websitewww.diesse.it
Exit Type
Secondary
Buyer
MOIC
Exit Year
2025

More from MED II

Other portfolio companies in the same fund.

Ceva Sante Animale
Ceva Sante Animale
Active
HealthcareFrance· 2025
Clean Biologics
Clean Biologics
Active
BiotechFrance· 2018
Provepharm
Provepharm
Active
BiotechFrance· 2018
Soest Medical Group
Soest Medical Group
Active
MedTechThe Netherlands· 2018

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Biocomposites
Biocomposites
Active
TA AssociatesUS
CMR Surgical
CMR Surgical
Active
LightrockUK
Neuromod Devices
Neuromod Devices
Active
Enterprise IrelandIreland
Optos
Exited 2015
Amadeus Capital PartnersUK
to
Ardos
Active
Delphinus Venture CapitalDenmark· 2026
Axomove
Axomove
Active
Go CapitalFrance· 2026
Track Diesse

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Diesse?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Diesse.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue